Articles

Export 82 results:

Filters: Keyword is Type 1 diabetes [Clear All Filters]

2019

Voglová B, Zahradnická M, Girman P, Kríž J, Berková Z, Koblas T, Vávrová E, Németová L, Kosinová L, Habart D et al.. 2019. Benefits of Islet Transplantation as an Alternative to Pancreas Transplantation: Retrospective Study of More Than 10 Ten Years of Experience in a Single Center. The Review Diabetic Studies. 14(1):10-21.

RevDiabeticStud-14-1-10.pdf (484.45 KB)

2017

Gregoriou E, Mamais I, Tzanetakou I, Lavranos G, Chrysostomou S. 2017. The Effects of Vitamin D Supplementation in Newly Diagnosed Type 1 Diabetes Patients: Systematic Review of Randomized Controlled Trials. The Review of Diabetic Studies. 14(2-3):260-268.

PDF (512.36 KB)

Søgaard KL, Ellervik C, Svensson J, Thorsen SU. 2017. The Role of Iron in Type 1 Diabetes Etiology: A Systematic Review of New Evidence on a Long-Standing Mystery. The Review of Diabetic Studies. 14(2-3):269-278.

PDF (284.41 KB)

2014

Krishnan R, Alexander M, Robles L, Foster, III CE, Lakey JRT. 2014. Islet and Stem Cell Encapsulation for Clinical Transplantation. The Review of Diabetic Studies. 11(1):84-101.

PDF (254.58 KB)

van der Meulen T, Huising MO. 2014. Maturation of Stem Cell-Derived Beta-cells Guided by the Expression of Urocortin 3. The Review of Diabetic Studies. 11(1):115-132.

PDF (601.52 KB)

2013

Hegazy SK, Tolba OA, Mostafa TM, Eid MA, El-Afify DR. 2013. Alpha-Lipoic Acid Improves Subclinical Left Ventricular Dysfunction in Asymptomatic Patients with Type 1 Diabetes. The Review of Diabetic Studies. 10(1):58-67.

PDF (255.43 KB)

Piccoli GB, Tavassoli E, Melluzza C, Grassi G, Monzeglio C, Donvito V, Leone F, Attini R, Ghiotto S, Clari R et al.. 2013. Severe Diabetic Nephropathy in Type 1 Diabetes and Pregnancy – A Case Series. The Review of Diabetic Studies. 10(1):68-78.

PDF (656.21 KB)

Piccoli GBarbara, Clari R, Ghiotto S, Castelluccia N, Colombi N, Mauro G, Tavassoli E, Melluzza C, Cabiddu G, Gernone G et al.. 2013. Type 1 Diabetes, Diabetic Nephropathy and Pregnancy: A Systematic Review and Meta-Study. The Review of Diabetic Studies. 10(1):6-26.

PDF (745.82 KB)

2012

Chatenoud L, Waldmann H. 2012. CD3 Monoclonal Antibodies: A First Step Towards Operational Immune Tolerance in the Clinic. The Review of Diabetic Studies. 9(4):372-381.

PDF (143.4 KB)

Coppieters KT, Hansen BSehested, von Herrath MG. 2012. Clinical Potential of Antigen-Specific Therapies in Type 1 Diabetes. The Review of Diabetic Studies. 9(4):328-337.

PDF (560.75 KB)

Driver JP, Chen Y-G, Mathews CE. 2012. Comparative Genetics: Synergizing Human and NOD Mouse Studies for Identifying Genetic Causation of Type 1 Diabetes. The Review of Diabetic Studies. 9(4):169-187.

PDF (345.36 KB)

Baxter AG, Jordan MA. 2012. From Markers to Molecular Mechanisms: Type 1 Diabetes in the Post-GWAS Era. The Review of Diabetic Studies. 9(4):201-223.

PDF (1.02 MB)

Holmes N, Cooke A. 2012. Genetic Analysis of Type 1 Diabetes: Embryonic Stem Cells as New Tools to Unlock Biological Mechanisms in Type 1 Diabetes. The Review of Diabetic Studies. 9(4):137-147.

PDF (170.47 KB)

Zaccone P, Hall SW. 2012. Helminth Infection and Type 1 Diabetes. The Review of Diabetic Studies. 9(4):272-286.

PDF (851.53 KB)

Weigmann B, Franke RKristina, Daniel C. 2012. Immunotherapy in Autoimmune Type 1 Diabetes. The Review of Diabetic Studies. 9(2-3):68-81.

PDF (186.38 KB)

Di Caro V, Giannoukakis N, Trucco M. 2012. In vivo Delivery of Nucleic Acid-Formulated Microparticles as a Potential Tolerogenic Vaccine for Type 1 Diabetes. The Review of Diabetic Studies. 9(4):348-356.

PDF (5.11 MB)

Mandrup-Poulsen T. 2012. Interleukin-1 Antagonists and Other Cytokine Blockade Strategies for Type 1 Diabetes. The Review of Diabetic Studies. 9(4):338-347.

PDF (204.6 KB)

Jin Y, She J-X. 2012. Novel Biomarkers in Type 1 Diabetes. The Review of Diabetic Studies. 9(4):224-235.

PDF (159.23 KB)

Graham KL, Sutherland RM, Mannering SI, Zhao Y, Chee J, Krishnamurthy B, Thomas HE, Lew AM, Kay TWH. 2012. Pathogenic Mechanisms in Type 1 Diabetes: The Islet is Both Target and Driver of Disease. The Review of Diabetic Studies. 9(4):148-168.

PDF (7.18 MB)

Cerosaletti K, Buckner JH. 2012. Protein Tyrosine Phosphatases and Type 1 Diabetes: Genetic and Functional Implications of PTPN2 and PTPN22. The Review of Diabetic Studies. 9(4):188-200.

PDF (763.08 KB)

Petzold C, Schallenberg S, Stern JNH, Kretschmer K. 2012. Targeted Antigen Delivery to DEC-205+ Dendritic Cells for Tolerogenic Vaccination. The Review of Diabetic Studies. 9(4):305-318.

PDF (379 KB)

Prasad S, Xu D, Miller SD. 2012. Tolerance Strategies Employing Antigen-Coupled Apoptotic Cells and Carboxylated PLG Nanoparticles for the Treatment of Type 1 Diabetes. The Review of Diabetic Studies. 9(4):319-327.

PDF (530.29 KB)

F Wong S, Wen L. 2012. Type 1 Diabetes Therapy Beyond T Cell Targeting: Monocytes, B Cells, and Innate Lymphocytes. The Review of Diabetic Studies. 9(4):289-304.

PDF (823.03 KB)

Nurminen N, Oikarinen S, Hyöty H. 2012. Virus Infections as Potential Targets of Preventive Treatments for Type 1 Diabetes. The Review of Diabetic Studies. 9(4):260-271.

PDF (416.12 KB)

2011

Regnell SE, Lernmark Å. 2011. Hepatic Steatosis in Type 1 Diabetes. The Review of Diabetic Studies. 8(4):454-467.

PDF (228.99 KB)

Articles

Pages

About